In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry
ISSUE In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry
(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
- MARKET ANALYSIS: CLINICAL CHEMISTRY
- OVERVIEW OF CLINICAL CHEMISTRY MARKET
- MARKET OUTLOOK
- Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
- Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
- Major Product Activity
- Lab-based Clinical Chemistry
- Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
- Point-of-Care Clinical Chemistry
- Table: Market Summary: POC-based Clinical Chemistry Market, 2023 and 2028 ($ millions)
- REGIONAL MARKET
- Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ millions)
- Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)
- TOP COMPANY BRIEFS
- Roche
- Abbott
- Danaher
- EXECUTIVE NEWS BRIEFING
- CUE HEALTH CALLS IT QUITS
- ALLENZ HEALTH SECURES $60 MILLION IN FUNDING
- NEXT GEN DIAGNOSTICS WELCOMES NEW SCIENTIFIC ADVISORY BOARD MEMBER
- NEXT GEN DIAGNOSTICS OPENS FIRST U.S. LABORATORY
- FINANCIAL HIGHLIGHTS: BIOMÉRIEUX & SEKISUI DIAGNOSTICS
- Figure: bioMérieux Sales Distribution, by Business Segment, 2023 (%)
- Table: bioMérieux Financial Review, by Business Segment, FY 2022 – FY 2-23 (€M)
- Figure: bioMérieux FY 2022 vs FY 2023 Regional Sales Breakdown (€M)
- Table: Sekisui Chemical Financial Results, FY 2022 and FY 2023 (Billions of Yen)
- Table: Sekisui Chemical Annual Overview and Focus, FY 2023 and FY 2024 (Billions of Yen)
- Table: Sekisui Chemical Net Sales, by Segment, FY22 and FY23 (Billions of Yen)
- Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 FY22 - Q4FY23 (Millions of Yen)
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- COVID-19/FLU UPDATE
- REGION WATCH
- JAPAN
- Figure: Japan National Health Expenditures, Year-on-Year Growth Rate, 1985-2019 (Yen trillion, %)
- Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
- Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds per Hospital, 2015-2019
- Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
- Figure: Japan IVD Market, by Segment, 2023 (%)
- BROAD-BASED COMPANY ANNOUNCEMENTS
- ANNOUNCEMENTS
- QIAGEN Launches Gastrointestinal Molecular Panel in the United States
- Illumina Spins Off Grail
- QIAGEN Discontinues NeuMoDx System
- DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
- Genetic Signatures Granted FDA Clearance for GI Kit
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook